Hongzhong Jin

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital

1 Shuaifuyuan

Beijing, 100730

China

SCHOLARLY PAPERS

1

DOWNLOADS

36

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

A Randomized, Double-Blind Phase III Study to Demonstrate the Clinical Similarity of Biosimilar SCT630 to Reference Adalimumab in Chinese Patients with Moderate to Severe Plaque Psoriasis

Number of pages: 27 Posted: 01 Jun 2022
Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Shandong First Medical University - Shandong Provincial Hospital, Tongji University - Shanghai Skin Disease Hospital, Jiangsu University - Affiliated Hospital, Tsinghua University - Beijing Tsinghua Changgung Hospital, Naval Medical University - Changhai Hospital, Shanxi Medical University - First Hospital, People's Hospital of Hangzhou Medical College - Zhejiang Provincial People's Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Shandong University - Qilu Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, Fudan University - Huashan Hospital, Sichuan University - West China Hospital, Southwest University - Southwest Hospital, Central South University - Second Xiangya Hospital, Government of the People's Republic of China - Air Force Medical Center, Central South University - Department of Dermatology, Kunming Medical University - Second Affiliated Hospital, Harbin Medical University - Second Affiliated Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Huazhong University of Science and Technology - Union Hospital, Sinocelltech Ltd., Sinocelltech Ltd. and Sinocelltech Ltd.
Downloads 36 (973,329)
Citation 1

Abstract:

Loading...

adalimumab, SCT630, plaque psoriasis